EI
HZNP

Ethic Inc’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Ethic Inc’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-4,410
Closed -$510K – 1114
2023
Q3 		$510K Sell
4,410
-95
-2% -$10.2K 0.02% 677
2023
Q2 		$463K Buy
4,505
+55
+1% +$5.8K 0.02% 676
2023
Q1 		$486K Buy
+4,450
New +$492K 0.02% 653

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Ethic Inc's HZNP Position: Q4 2023 in Review

Ethic Inc sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 4,410 shares — an estimated $510K sold.

Ethic Inc first reported a position in HZNP in Q1 2023 and held it in 3 quarters. The position peaked at $510K in Q3 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Ethic Inc reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Ethic Inc sold 4,410 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $510K.
  • Ethic Inc first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2023 and held it in 3 quarters.
  • Ethic Inc's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $510K in Q3 2023.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Ethic Inc's 13F filing for Q4 2023, filed 14 Feb 2024.